Fluorodeoxyglucose Myocardial Accumulation to Assess Response to Immunosuppressive Treatment in Cardiac Sarcoidosis
JACC: Cardiovascular Imaging · 2024-01 · 17 (1) · 59-61
DOI: 10.1016/j.jcmg.2023.06.024 ↗Kurz gefasst
Editorial in der Zeitschrift JACC: Cardiovascular Imaging, 2024-01. Verfasst von Leslie T Cooper und 1 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic, Jacksonville, Florida, USA. Electronic address: Cooper.leslie@mayo.edu. Hauptthemen laut MEDLINE: Myocarditis, Sarcoidosis, Cardiomyopathies. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mayo Clinic, Jacksonville, Florida, USA. Electronic address: Cooper.leslie@mayo.edu.
- Mayo Clinic, Jacksonville, Florida, USA.
Zitieren
APA
Cooper, L. T., & Reddy, P. (2024). Fluorodeoxyglucose Myocardial Accumulation to Assess Response to Immunosuppressive Treatment in Cardiac Sarcoidosis. JACC: Cardiovascular Imaging, 17(1), 59-61. https://doi.org/10.1016/j.jcmg.2023.06.024
Vancouver
Cooper LT, Reddy P. Fluorodeoxyglucose Myocardial Accumulation to Assess Response to Immunosuppressive Treatment in Cardiac Sarcoidosis. JACC: Cardiovascular Imaging. 2024;17(1):59-61. doi:10.1016/j.jcmg.2023.06.024
BibTeX
@article{Cooper2024,
author = {Cooper, Leslie T and Reddy, Prajwal},
title = {Fluorodeoxyglucose Myocardial Accumulation to Assess Response to Immunosuppressive Treatment in Cardiac Sarcoidosis},
journal = {JACC: Cardiovascular Imaging},
year = {2024},
volume = {17},
number = {1},
pages = {59--61},
doi = {10.1016/j.jcmg.2023.06.024}
}
EUVIMED